Product Information

ALLOPURINOL 300 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0546 per EA under NDC 00904657261. Its NADAC has been published 495 times since Mar 1, 2017.

FDA first approved this application on Jun 27, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ALLOPURINOL 300 MG TABLET

allopurinol
$0.0546per EA

Strength

300 mg/1

NDC

00904657261

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ALLOPURINOL

Approval Type

Generic (ANDA)

FDA Application

ANDA075798

FDA Approved

6/27/2003

TE Code

AB

On Market Since

6/27/2003

Pharmacological Classes

Xanthine Oxidase Inhibitor
Xanthine Oxidase Inhibitors

Price Statistics

The NADAC for ALLOPURINOL 300 MG TABLET has been published 495 times since Mar 1, 2017, and over the history we have for it it has declined 78.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0546 per EA
All-time high$0.2558 (Mar 15, 2017)
All-time low$0.0546 (Aug 19, 2026)
52-week high$0.0674
52-week low$0.0546
Median price$0.0893
Average price$0.1039
Largest weekly change-17.2% (Dec 20, 2017)
Weeks tracked495
Tracking sinceMar 1, 2017

Price History

1W

-2.2%

1M

-2.2%

3M

-3.0%

6M

-7.2%

1Y

-18.9%

3Y

-31.4%

5Y

-50.9%

All

-78.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ALLOPURINOL 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ALLOPURINOL 300 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0546 per EA (NDC 00904657261), effective Aug 19, 2026.

How has the price of ALLOPURINOL 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for ALLOPURINOL 300 MG TABLET has declined 78.6%. It has been tracked across 495 weekly CMS publications since Mar 1, 2017.

What are the highest and lowest recorded NADAC prices for ALLOPURINOL 300 MG TABLET?

Since Mar 1, 2017, the NADAC for ALLOPURINOL 300 MG TABLET has ranged from a low of $0.0546 (Aug 19, 2026) to a high of $0.2558 (Mar 15, 2017), with a median of $0.0893 per EA.

Are there cheaper alternatives to ALLOPURINOL 300 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ALLOPURINOL 300 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ALLOPURINOL 300 MG TABLET?

ALLOPURINOL 300 MG TABLET (NDC 00904657261) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.